{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:02:35Z","timestamp":1781208155029,"version":"3.54.1"},"reference-count":100,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The angiotensin-converting enzyme-2 (ACE-2) alters the pathophysiology of various\nfatal cardiovascular diseases, including ischemic heart disease, whereas angiotensin 1-7 (Ang\n1\u20137) exerts a wide range of actions. The effects of ischemia-reperfusion (IR) injury include\ndamage to myocardial tissue that initiates protease action, causing cardiac cell death. Angiotensin-\nII (Ang-II) contributes through the renin-angiotensin system (RAS) to the IR injury, whereas\nAng 1\u20137 paradoxically exerts a protective effect through the same. Thus, the myocardial ischemic\nreperfusion injury (MIRI) may be altered by the RAS of the heart. This review paper\nfocuses on ACE-2, angiotensin-converting enzyme (ACE), and Ang 1\u20137 regulation in the RAS\nof the heart in the pathophysiology of MIRI. The treatment in such conditions using ACE-2 activator,\nACE inhibitor, and Ang-II antagonists may promote vascular functions as well as cardio-\nprotection.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0125899775280160240122065607","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T10:04:24Z","timestamp":1706781864000},"page":"102-112","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulation of Angiotensin-II and Angiotensin 1-7 Levels Influences Cardiac Function in Myocardial Ischemia-reperfusion Injury"],"prefix":"10.2174","volume":"17","author":[{"given":"Prabhat Kumar","family":"Upadhyay","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Pharmacology,\nAll India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Kumar","family":"Vishwakarma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology,\nAll India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hridaya Shankar","family":"Chaurasiya","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Jyotiraditya Institute of\nPharmacy, Pratapgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarique Mahmood","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mjafi.2019.12.005","volume":"76","author":"Sreeniwas Kumar A.","year":"2020","unstructured":"Sreeniwas Kumar A.; Sinha N.; Cardiovascular disease in India: A 360 degree overview. Med J Armed Forces India  2020,76(1),1-3","journal-title":"Med J Armed Forces India"},{"key":"ref=2","first-page":"222","volume":"4","author":"Nag T.","year":"2013","unstructured":"Nag T.; Ghosh A.; Cardiovascular disease risk factors in Asian Indian population: A systematic review. J Cardiovasc Dis Res  2013,4(4),222-228","journal-title":"J Cardiovasc Dis Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4065\/mcp.2009.0560","volume":"85","author":"Kontos M.C.","year":"2010","unstructured":"Kontos M.C.; Diercks D.B.; Kirk J.D.; Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc  2010,85(3),284-299","journal-title":"Mayo Clin Proc"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jsha.2016.09.002","volume":"29","author":"Goyal A.","year":"2017","unstructured":"Goyal A.; Agrawal N.; Ischemic preconditioning: Interruption of various disorders. J Saudi Heart Assoc  2017,29(2),116-127","journal-title":"J Saudi Heart Assoc"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/pr.113.008300","volume":"66","author":"Ferdinandy P.","year":"2014","unstructured":"Ferdinandy P.; Hausenloy D.J.; Heusch G.; Baxter G.F.; Schulz R.; Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev  2014,66(4),1142-1174","journal-title":"Pharmacol Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1741-7015-11-250","volume":"11","author":"Charlson F.J.","year":"2013","unstructured":"Charlson F.J.; Moran A.E.; Freedman G.; The contribution of major depression to the global burden of ischemic heart disease: A comparative risk assessment. BMC Med  2013,11(1),250","journal-title":"BMC Med"},{"key":"ref=7","first-page":"774","volume":"38","author":"Heusch G.","year":"2017","unstructured":"Heusch G.; Gersh B.J.; The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: A continual challenge. Eur Heart J  2017,38(11),774-784","journal-title":"Eur Heart J"},{"key":"ref=8","first-page":"8","volume":"5","author":"Philip F.","year":"2015","unstructured":"Philip F.; Blackstone E.; Kapadia S.R.; Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery. Cardiovasc Diagn Ther  2015,5(1),8-16","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/CS20150223","volume":"129","author":"Gracia-Sancho J.","year":"2015","unstructured":"Gracia-Sancho J.; Casillas-Ram\u00edrez A.; Peralta C.; Molecular pathways in protecting the liver from ischaemia\/reperfusion injury: A 2015 update. Clin Sci  2015,129(4),345-362","journal-title":"Clin Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1113\/JP273408","volume":"595","author":"Jespersen N.R.","year":"2017","unstructured":"Jespersen N.R.; Yokota T.; St\u00f8ttrup N.B.; Pre\u2010ischaemic mitochondrial substrate constraint by inhibition of malate\u2010aspartate shuttle preserves mitochondrial function after ischaemia\u2013reperfusion. J Physiol  2017,595(12),3765-3780","journal-title":"J Physiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1159\/000489241","volume":"46","author":"Wu M.Y.","year":"2018","unstructured":"Wu M.Y.; Yiang G.T.; Liao W.T.; Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem  2018,46(4),1650-1667","journal-title":"Cell Physiol Biochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cjca.2012.01.017","volume":"28","author":"Montezano A.C.","year":"2012","unstructured":"Montezano A.C.; Touyz R.M.; Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: A basic science update for the clinician. Can J Cardiol  2012,28(3),288-295","journal-title":"Can J Cardiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3389\/fphys.2020.00694","volume":"11","author":"Sharifi-Rad M.","year":"2020","unstructured":"Sharifi-Rad M.; Anil Kumar N.V.; Zucca P.; Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol  2020,11,694","journal-title":"Front Physiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuropharm.2018.07.006","volume":"139","author":"Rana A.K.","year":"2018","unstructured":"Rana A.K.; Singh D.; Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: Opportunities, challenges and future directions for cerebral stroke management. Neuropharmacology  2018,139,124-136","journal-title":"Neuropharmacology"},{"key":"ref=15","first-page":"28","volume":"10","author":"Lamendola P.","year":"2009","unstructured":"Lamendola P.; Di Monaco A.; Barone L.; Pisanello C.; Lanza G.A.; Crea F.; Mechanisms of myocardial cell protection from ischemia\/reperfusion injury and potential clinical implications. G Ital Cardiol  2009,10(1),28-36","journal-title":"G Ital Cardiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.freeradbiomed.2010.11.030","volume":"50","author":"Petrosillo G.","year":"2011","unstructured":"Petrosillo G.; Di Venosa N.; Moro N.; In vivo  hyperoxic preconditioning protects against rat-heart ischemia\/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Free Radic Biol Med  2011,50(3),477-483","journal-title":"Free Radic Biol Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00395-009-0004-8","volume":"104","author":"Baines C.P.","year":"2009","unstructured":"Baines C.P.; The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol  2009,104(2),181-188","journal-title":"Basic Res Cardiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"Brentnall M.","year":"2013","unstructured":"Brentnall M.; Rodriguez-Menocal L.; De Guevara R.L.; Cepero E.; Boise L.H.; Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol  2013,14(1),32","journal-title":"BMC Cell Biol"},{"key":"ref=19","first-page":"2217","volume":"127","author":"Brentnall M.","year":"2014","unstructured":"Brentnall M.; Weir D.B.; Rongvaux A.; Marcus A.I.; Boise L.H.; Procaspase-3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function. J Cell Sci  2014,127(Pt 10),2217-2226","journal-title":"J Cell Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00018-015-2094-9","volume":"73","author":"Messner B.","year":"2016","unstructured":"Messner B.; T\u00fcrkcan A.; Ploner C.; Laufer G.; Bernhard D.; Cadmium overkill: Autophagy, apoptosis and necrosis signalling in endothelial cells exposed to cadmium. Cell Mol Life Sci  2016,73(8),1699-1713","journal-title":"Cell Mol Life Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","volume":"117","author":"Cadenas S.","year":"2018","unstructured":"Cadenas S.; ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med  2018,117,76-89","journal-title":"Free Radic Biol Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jacbts.2019.01.009","volume":"4","author":"Houang E.M.","year":"2019","unstructured":"Houang E.M.; Bartos J.; Hackel B.J.; Cardiac muscle membrane stabilization in myocardial reperfusion injury. JACC Basic Transl Sci  2019,4(2),275-287","journal-title":"JACC Basic Transl Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lfs.2016.09.013","volume":"165","author":"Bagheri F.","year":"2016","unstructured":"Bagheri F.; Khori V.; Alizadeh A.M.; Khalighfard S.; Khodayari S.; Khodayari H.; Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies. Life Sci  2016,165,43-55","journal-title":"Life Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"927061","DOI":"10.3389\/fcvm.2022.927061","volume":"9","author":"Zheng Y.","year":"2022","unstructured":"Zheng Y.; Xu L.; Dong N.; Li F.; NLRP3 inflammasome: The rising star in cardiovascular diseases. Front Cardiovasc Med  2022,9,927061","journal-title":"Front Cardiovasc Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10557-010-6234-z","volume":"24","author":"Miura T.","year":"2010","unstructured":"Miura T.; Tanno M.; Mitochondria and GSK-3beta in cardioprotection against ischemia\/reperfusion injury. Cardiovasc Drugs Ther  2010,24(3),255-263","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1042\/BST0340232","volume":"34","author":"Halestrap A.P.","year":"2006","unstructured":"Halestrap A.P.; Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans  2006,34(2),232-237","journal-title":"Biochem Soc Trans"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s13105-018-0633-1","volume":"74","author":"Thirupathi A.","year":"2018","unstructured":"Thirupathi A.; Pinho R.A.; Effects of reactive oxygen species and interplay of antioxidants during physical exercise in skeletal muscles. J Physiol Biochem  2018,74(3),359-367","journal-title":"J Physiol Biochem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7018393","volume":"2017","author":"Neri M.","year":"2017","unstructured":"Neri M.; Riezzo I.; Pascale N.; Pomara C.; Turillazzi E.; Ischemia\/reperfusion injury following acute myocardial infarction: A critical issue for clinicians and forensic pathologists. Mediators Inflamm  2017,2017,1-14","journal-title":"Mediators Inflamm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5500\/wjt.v13.i3.58","volume":"13","author":"Avtaar Singh S.S.","year":"2023","unstructured":"Avtaar Singh S.S.; Das De S.; Al-Adhami A.; Singh R.; Hopkins P.M.A.; Curry P.A.; Primary graft dysfunction following lung transplantation: From pathogenesis to future frontiers. World J Transplant  2023,13(3),58-85","journal-title":"World J Transplant"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1399-0012.2010.01319.x","volume":"25","author":"Herrington C.S.","year":"2011","unstructured":"Herrington C.S.; Prekker M.E.; Arrington A.K.; A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation. Clin Transplant  2011,25(1),90-96","journal-title":"Clin Transplant"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","volume":"6","author":"Granger D.N.","year":"2015","unstructured":"Granger D.N.; Kvietys P.R.; Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol  2015,6,524-551","journal-title":"Redox Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/ijms19061739","volume":"19","author":"Kotyla P.","year":"2018","unstructured":"Kotyla P.; Bimodal function of anti-TNF treatment: Shall we be concerned about anti-tnf treatment in patients with rheumatoid arthritis and heart failure? Int J Mol Sci  2018,19(6),1739","journal-title":"Int J Mol Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.2337\/dc08-s247","volume":"31","author":"Paravicini T.M.","year":"2008","unstructured":"Paravicini T.M.; Touyz R.M.; NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care  2008,31(Suppl. 2),S170-S180","journal-title":"Diabetes Care"},{"key":"ref=34","first-page":"20","volume":"4","author":"Malek M.","year":"2015","unstructured":"Malek M.; Nematbakhsh M.; Renal ischemia\/reperfusion injury: From pathophysiology to treatment. J Renal Inj Prev  2015,4(2),20-27","journal-title":"J Renal Inj Prev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2008.08.016","volume":"130","author":"Jang H.R.","year":"2009","unstructured":"Jang H.R.; Rabb H.; The innate immune response in ischemic acute kidney injury. Clin Immunol  2009,130(1),41-50","journal-title":"Clin Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrneph.2011.16","volume":"7","author":"Sharfuddin A.A.","year":"2011","unstructured":"Sharfuddin A.A.; Molitoris B.A.; Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol  2011,7(4),189-200","journal-title":"Nat Rev Nephrol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.transproceed.2006.12.012","volume":"39","author":"de Groot H.","year":"2007","unstructured":"de Groot H.; Rauen U.; Ischemia-reperfusion injury: Processes in pathogenetic networks: A review. Transplant Proc  2007,39(2),481-484","journal-title":"Transplant Proc"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.3390\/nu5103779","volume":"5","author":"Khurana S.","year":"2013","unstructured":"Khurana S.; Venkataraman K.; Hollingsworth A.; Piche M.; Tai T.; Polyphenols: Benefits to the cardiovascular system in health and in aging. Nutrients  2013,5(10),3779-3827","journal-title":"Nutrients"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2019.02.031","volume":"135","author":"Yu H.","year":"2019","unstructured":"Yu H.; Kalogeris T.; Korthuis R.J.; Reactive species-induced microvascular dysfunction in ischemia\/reperfusion. Free Radic Biol Med  2019,135,182-197","journal-title":"Free Radic Biol Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2261-11-43","volume":"11","author":"Ajmani P.","year":"2011","unstructured":"Ajmani P.; Yadav H.N.; Singh M.; Sharma P.L.; Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord  2011,11(1),43","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1177\/0960327116673169","volume":"36","author":"Gupta I.","year":"2017","unstructured":"Gupta I.; Goyal A.; Singh N.K.; Yadav H.N.; Sharma P.L.; Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart. Hum Exp Toxicol  2017,36(8),867-875","journal-title":"Hum Exp Toxicol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"Heusch G.","year":"2020","unstructured":"Heusch G.; Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol  2020,17(12),773-789","journal-title":"Nat Rev Cardiol"},{"key":"ref=43","first-page":"935","volume":"38","author":"Hausenloy D.J.","year":"2017","unstructured":"Hausenloy D.J.; Botker H.E.; Engstrom T.; Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: Trials and tribulations. Eur Heart J  2017,38(13),935-941","journal-title":"Eur Heart J"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/icvts\/ivu432","volume":"20","author":"Minasian S.M.","year":"2015","unstructured":"Minasian S.M.; Galagudza M.M.; Dmitriev Y.V.; Karpov A.A.; Vlasov T.D.; Preservation of the donor heart: From basic science to clinical studies. Interact Cardiovasc Thorac Surg  2015,20(4),510-519","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.yexmp.2015.06.020","volume":"99","author":"Jonecova Z.","year":"2015","unstructured":"Jonecova Z.; Toth S.; Maretta M.; Protective effect of ischemic preconditioning on the jejunal graft mucosa injury during cold preservation. Exp Mol Pathol  2015,99(2),229-235","journal-title":"Exp Mol Pathol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10557-005-6900-8","volume":"19","author":"Pagliaro P.","year":"2005","unstructured":"Pagliaro P.; Penna C.; Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther  2005,19(1),77-87","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00395-009-0075-6","volume":"105","author":"Penna C.","year":"2010","unstructured":"Penna C.; Tullio F.; Moro F.; Folino A.; Merlino A.; Pagliaro P.; Effects of a protocol of ischemic postconditioning and\/or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol  2010,105(2),181-192","journal-title":"Basic Res Cardiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","volume":"75","author":"Ferdinandy P.","year":"2023","unstructured":"Ferdinandy P.; Andreadou I.; Baxter G.F.; Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia\/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning. Pharmacol Rev  2023,75(1),159-216","journal-title":"Pharmacol Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(11)60699-5","volume":"378","author":"Nankivell B.J.","year":"2011","unstructured":"Nankivell B.J.; Kuypers D.R.J.; Diagnosis and prevention of chronic kidney allograft loss. Lancet  2011,378(9800),1428-1437","journal-title":"Lancet"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ejphar.2014.08.016","volume":"746","author":"Randhawa P.K.","year":"2015","unstructured":"Randhawa P.K.; Bali A.; Jaggi A.S.; RIPC for multiorgan salvage in clinical settings: Evolution of concept, evidences and mechanisms. Eur J Pharmacol  2015,746,317-332","journal-title":"Eur J Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bpa.2022.09.002","volume":"36","author":"P\u00fcchel J.","year":"2022","unstructured":"P\u00fcchel J.; Sitter M.; Kranke P.; Pecks U.; Procedural techniques to control postpartum hemorrhage. Baillieres Best Pract Res Clin Anaesthesiol  2022,36(3-4),371-382","journal-title":"Baillieres Best Pract Res Clin Anaesthesiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3892\/mmr.2014.2917","volume":"11","author":"Guo L.","year":"2015","unstructured":"Guo L.; Sun G.; Wang G.; Ning W.; Zhao K.; Soluble P-selectin promotes acute myocardial infarction onset but not severity. Mol Med Rep  2015,11(3),2027-2033","journal-title":"Mol Med Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fimmu.2019.00300","volume":"10","author":"Weil B.R.","year":"2019","unstructured":"Weil B.R.; Neelamegham S.; Selectins and immune cells in acute myocardial infarction and post-infarction ventricular remodeling: Pathophysiology and novel treatments. Front Immunol  2019,10,300","journal-title":"Front Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1472-8206.2007.00491.x","volume":"21","author":"Oh K.S.","year":"2007","unstructured":"Oh K.S.; Seo H.W.; Yi K.Y.; Lee S.; Yoo S.; Lee B.H.; Effects of KR\u201033028, a novel Na +\/H + exchanger\u20101 inhibitor, on ischemia and reperfusion\u2010induced myocardial infarction in rats and dogs. Fundam Clin Pharmacol  2007,21(3),255-263","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","volume":"107","author":"Sim\u00f5es e Silva A.C.","year":"2016","unstructured":"Sim\u00f5es e Silva A.C.; Teixeira M.M.; ACE inhibition, ACE2 and angiotensin-(1\u2fff7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res  2016,107,154-162","journal-title":"Pharmacol Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e0128141","DOI":"10.1371\/journal.pone.0128141","volume":"10","author":"Lima C.T.","year":"2015","unstructured":"Lima C.T.; Silva J.C.S.; Viegas K.A.S.; Increase in vascular injury of sodium overloaded mice may be related to vascular angiotensin modulation. PLoS One  2015,10(6),e0128141","journal-title":"PLoS One"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1440-1681.2007.04556.x","volume":"34","author":"De Resende M.M.","year":"2007","unstructured":"De Resende M.M.; Mill J.G.; Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats. Clin Exp Pharmacol Physiol  2007,34(4),274-279","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"Paul M.","year":"2006","unstructured":"Paul M.; Poyan Mehr A.; Kreutz R.; Physiology of local renin-angiotensin systems. Physiol Rev  2006,86(3),747-803","journal-title":"Physiol Rev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.yjmcc.2010.12.003","volume":"51","author":"Iwata M.","year":"2011","unstructured":"Iwata M.; Cowling R.T.; Yeo S.J.; Greenberg B.; Targeting the ACE2\u2013Ang-(1\u20137) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure. J Mol Cell Cardiol  2011,51(4),542-547","journal-title":"J Mol Cell Cardiol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"Hamming I.","year":"2004","unstructured":"Hamming I.; Timens W.; Bulthuis M.L.C.; Lely A.T.; Navis G.J.; van Goor H.; Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol  2004,203(2),631-637","journal-title":"J Pathol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.drudis.2010.02.003","volume":"15","author":"Shi L.","year":"2010","unstructured":"Shi L.; Mao C.; Xu Z.; Zhang L.; Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. Drug Discov Today  2010,15(9-10),332-341","journal-title":"Drug Discov Today"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4070\/kcj.2007.37.3.91","volume":"37","author":"Ryu W.S.","year":"2007","unstructured":"Ryu W.S.; Kim S.W.; Kim C.J.; Overview of the renin-angiotensin system. Korean Circ J  2007,37(3),91-96","journal-title":"Korean Circ J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000329926","volume":"1","author":"Hayden M.R.","year":"2011","unstructured":"Hayden M.R.; Sowers K.M.; Pulakat L.; Possible mechanisms of local tissue renin-angiotensin system activation in the cardiorenal metabolic syndrome and type 2 diabetes mellitus. Cardiorenal Med  2011,1(3),193-210","journal-title":"Cardiorenal Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1113\/expphysiol.2013.074336","volume":"99","author":"Sabharwal R.","year":"2014","unstructured":"Sabharwal R.; Chapleau M.W.; Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: Targeting the renin\u2013angiotensin system. Exp Physiol  2014,99(4),627-631","journal-title":"Exp Physiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e11111","DOI":"10.1371\/journal.pone.0011111","volume":"5","author":"Gutte H.","year":"2010","unstructured":"Gutte H.; Oxb\u00f8l J.; Kristoffersen U.S.; Mortensen J.; Kj\u00e6r A.; Gene expression of ANP, BNP and ET-1 in the heart of rats during pulmonary embolism. PLoS One  2010,5(6),e11111","journal-title":"PLoS One"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.peptides.2014.08.016","volume":"61","author":"Marangoni R.A.","year":"2014","unstructured":"Marangoni R.A.; Santos R.A.; Piccolo C.; Deficient prolylcarboxypeptidase gene and protein expression in left ventricles of spontaneously hypertensive rats (SHR). Peptides  2014,61,69-74","journal-title":"Peptides"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cphy.c130040","volume":"4","author":"Sparks M.A.","year":"2014","unstructured":"Sparks M.A.; Crowley S.D.; Gurley S.B.; Mirotsou M.; Coffman T.M.; Classical renin-angiotensin system in kidney physiology. Compr Physiol  2014,4(3),1201-1228","journal-title":"Compr Physiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1590\/2175-8239-jbn-3661","volume":"40","author":"Gonsalez S.R.","year":"2018","unstructured":"Gonsalez S.R.; Ferr\u00e3o F.M.; Souza A.M.; Lowe J.; Morcillo L.S.L.; Inappropriate activity of local renin-angiotensin-aldosterone system during high salt intake: Impact on the cardio-renal axis. J Bras Nefrol  2018,40(2),170-178","journal-title":"J Bras Nefrol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/1440-1681.12553","volume":"43","author":"Huskov\u00e1 Z.","year":"2016","unstructured":"Huskov\u00e1 Z.; Kopkan L.; \u010cervenkov\u00e1 L.; Intrarenal alterations of the angiotensin\u2010converting enzyme type 2\/angiotensin 1\u20137 complex of the renin\u2010angiotensin system do not alter the course of malignant hypertension in Cyp1a1\u2010Ren\u20102 transgenic rats. Clin Exp Pharmacol Physiol  2016,43(4),438-449","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4161\/jkst.22729","volume":"1","author":"Satou R.","year":"2012","unstructured":"Satou R.; Gonzalez-Villalobos R.A.; JAK-STAT and the renin-angiotensin system. JAK-STAT  2012,1(4),250-256","journal-title":"JAK-STAT"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","volume":"126","author":"Roshanov P.S.","year":"2017","unstructured":"Roshanov P.S.; Rochwerg B.; Patel A.; Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: An analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort. Anesthesiology  2017,126(1),16-27","journal-title":"Anesthesiology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.RES.0000180753.63183.95","volume":"97","author":"Min L.J.","year":"2005","unstructured":"Min L.J.; Mogi M.; Li J.M.; Iwanami J.; Iwai M.; Horiuchi M.; Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ Res  2005,97(5),434-442","journal-title":"Circ Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/01.HYP.0000182660.74266.6d","volume":"46","author":"Zhang Y.","year":"2005","unstructured":"Zhang Y.; Griendling K.K.; Dikalova A.; Owens G.K.; Taylor W.R.; Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension  2005,46(4),732-737","journal-title":"Hypertension"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/01.RES.0000185322.46009.F5","volume":"97","author":"Ushio-Fukai M.","year":"2005","unstructured":"Ushio-Fukai M.; Zuo L.; Ikeda S.; Tojo T.; Patrushev N.A.; Alexander R.W.; cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circ Res  2005,97(8),829-836","journal-title":"Circ Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"39353","DOI":"10.1074\/jbc.M508914200","volume":"280","author":"Warner F.J.","year":"2005","unstructured":"Warner F.J.; Lew R.A.; Smith A.I.; Lambert D.W.; Hooper N.M.; Turner A.J.; Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem  2005,280(47),39353-39362","journal-title":"J Biol Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1570159X11311020007","volume":"11","author":"Jiang T.","year":"2013","unstructured":"Jiang T.; Gao L.; Lu J.; Zhang Y.D.; ACE2-Ang-(1-7)-Mas axis in brain: A potential target for prevention and treatment of ischemic stroke. Curr Neuropharmacol  2013,11(2),209-217","journal-title":"Curr Neuropharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fcimb.2020.00317","volume":"10","author":"Samavati L.","year":"2020","unstructured":"Samavati L.; Uhal B.D.; ACE2, much more than just a receptor for SARS-COV-2. Front Cell Infect Microbiol  2020,10,317","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"Gheblawi M.","year":"2020","unstructured":"Gheblawi M.; Wang K.; Viveiros A.; Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system. Circ Res  2020,126(10),1456-1474","journal-title":"Circ Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"Forrester S.J.","year":"2018","unstructured":"Forrester S.J.; Booz G.W.; Sigmund C.D.; Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology. Physiol Rev  2018,98(3),1627-1738","journal-title":"Physiol Rev"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00805561","volume":"92","author":"Solomon S.D.","year":"1997","unstructured":"Solomon S.D.; Pfeffer M.A.; The decreasing incidence of left ventricular remodeling following myocardial infarction. Basic Res Cardiol  1997,92(2),61-65","journal-title":"Basic Res Cardiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","volume":"2","author":"Zhang T.","year":"2021","unstructured":"Zhang T.; Ma C.; Zhang Z.; Zhang H.; Hu H.; NF\u2010\u03baB signaling in inflammation and cancer. MedComm  2021,2(4),618-653","journal-title":"MedComm"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/01.CIR.90.3.1368","volume":"90","author":"Ehring T.","year":"1994","unstructured":"Ehring T.; Baumgart D.; Krajcar M.; H\u00fcmmelgen M.; Kompa S.; Heusch G.; Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation  1994,90(3),1368-1385","journal-title":"Circulation"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"Frangogiannis N.G.","year":"2020","unstructured":"Frangogiannis N.G.; Transforming growth factor\u2013\u03b2 in tissue fibrosis. J Exp Med  2020,217(3),e20190103","journal-title":"J Exp Med"},{"key":"ref=84","first-page":"50","volume":"9","author":"Sousa-Lopes A.","year":"2020","unstructured":"Sousa-Lopes A.; de Freitas R.A.; Carneiro F.S.; Angiotensin (1-7) inhibits Ang II-mediated ERK1\/2 activation by stimulating MKP-1 activation in vascular smooth muscle cells. Int J Mol Cell Med  2020,9(1),50-61","journal-title":"Int J Mol Cell Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S0735-1097(98)00441-0","volume":"32","author":"Jalowy A.","year":"1998","unstructured":"Jalowy A.; Schulz R.; D\u00f6rge H.; Behrends M.; Heusch G.; Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol  1998,32(6),1787-1796","journal-title":"J Am Coll Cardiol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s003950050144","volume":"94","author":"D\u00f6rge H.","year":"1999","unstructured":"D\u00f6rge H.; Behrends M.; Schulz R.; Jalowy A.; Heusch G.; Attenuation of myocardial stunning by the AT 1 receptor antagonist candesartan. Basic Res Cardiol  1999,94(3),208-214","journal-title":"Basic Res Cardiol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","volume":"91-92","author":"AlQudah M.","year":"2020","unstructured":"AlQudah M.; Hale T.M.; Czubryt M.P.; Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix Biol  2020,91-92,92-108","journal-title":"Matrix Biol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"Ong S.B.","year":"2018","unstructured":"Ong S.B.; Hern\u00e1ndez-Res\u00e9ndiz S.; Crespo-Avilan G.E.; Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther  2018,186,73-87","journal-title":"Pharmacol Ther"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e0165777","DOI":"10.1371\/journal.pone.0165777","volume":"11","author":"Babiker F.","year":"2016","unstructured":"Babiker F.; Al-Jarallah A.; Joseph S.; The interplay between the renin angiotensin system and pacing postconditioning induced cardiac protection. PLoS One  2016,11(11),e0165777","journal-title":"PLoS One"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1568006053004994","volume":"5","author":"Meier P.","year":"2005","unstructured":"Meier P.; Maillard M.; Burnier M.; The future of angiotensin II inhibition in cardiovascular medicine. Curr Drug Targets Cardiovasc Haematol Disord  2005,5(1),15-30","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","volume":"62","author":"Qi Y.","year":"2013","unstructured":"Qi Y.; Zhang J.; Cole-Jeffrey C.T.; Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension  2013,62(4),746-752","journal-title":"Hypertension"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.biopha.2018.07.170","volume":"107","author":"Castardeli C.","year":"2018","unstructured":"Castardeli C.; Sart\u00f3rio C.L.; Pimentel E.B.; Forechi L.; Mill J.G.; The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats. Biomed Pharmacother  2018,107,212-218","journal-title":"Biomed Pharmacother"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0188-4409(03)00076-6","volume":"34","author":"Mart\u00ednez L.A.","year":"2003","unstructured":"Mart\u00ednez L.A.; Villalobos-Molina R.; Early and chronic captopril or Losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats. Arch Med Res  2003,34(5),357-361","journal-title":"Arch Med Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fmed.2020.00335","volume":"7","author":"Pagliaro P.","year":"2020","unstructured":"Pagliaro P.; Penna C.; ACE\/ACE2 ratio: A key also in 2019 coronavirus disease (Covid-19)? Front Med  2020,7,335","journal-title":"Front Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1159\/000430274","volume":"36","author":"Huang J.","year":"2015","unstructured":"Huang J.; Tang X.; Liang X.; The effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone on pressure overload-induced cardiac remodeling in rats and the endothelial mechanisms based on PGI2. Cell Physiol Biochem  2015,36(3),1004-1014","journal-title":"Cell Physiol Biochem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fnins.2020.00650","volume":"14","author":"Xue B.","year":"2020","unstructured":"Xue B.; Zhang Y.; Johnson A.K.; Interactions of the brain renin-angiotensin-system (RAS) and inflammation in the sensitization of hypertension. Front Neurosci  2020,14,650","journal-title":"Front Neurosci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13054-020-02862-1","volume":"24","author":"Busse L.W.","year":"2020","unstructured":"Busse L.W.; Chow J.H.; McCurdy M.T.; Khanna A.K.; COVID-19 and the RAAS\u2014a potential role for angiotensin II? Crit Care  2020,24(1),136","journal-title":"Crit Care"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.dsx.2020.03.016","volume":"14","author":"Singh A.K.","year":"2020","unstructured":"Singh A.K.; Gupta R.; Misra A.; Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr  2020,14(4),283-287","journal-title":"Diabetes Metab Syndr"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1111\/bph.15207","volume":"177","author":"Penna C.","year":"2020","unstructured":"Penna C.; Mercurio V.; Tocchetti C.G.; Pagliaro P.; Sex\u2010related differences in COVID\u201019 lethality. Br J Pharmacol  2020,177(19),4375-4385","journal-title":"Br J Pharmacol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fped.2020.00206","volume":"8","author":"Ciaglia E.","year":"2020","unstructured":"Ciaglia E.; Vecchione C.; Puca A.A.; COVID-19 infection and circulating ACE2 levels: Protective role in women and children. Front Pediatr  2020,8,206","journal-title":"Front Pediatr"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775280160240122065607","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226557\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775280160240122065607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:06:34Z","timestamp":1741241194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226557\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0125899775280160240122065607","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}